Skip to main content

INTELLIGENT BIO SOLUTIONS INC.

corporate_fare Company Profile

INTELLIGENT BIO SOLUTIONS INC.

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed INBS - Latest Insights

INBS
Apr 20, 2026, 9:15 AM EDT
Source: GlobeNewswire
Importance Score:
8
Drug Screening Cartridge Validation Targets 70% Faster Results, Eyes $1.6B Roadside Market
Sentiment: Positive
View Wiseek Article
INBS
Apr 20, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Intelligent Bio Solutions Reports 8.8% Increase in Shares Outstanding from Warrant Exercises and ATM Sales
Sentiment: Negative
View Wiseek Article
INBS
Apr 17, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Intelligent Bio Solutions Clears Key FDA Hurdle with Flawless Security Testing
Sentiment: Positive
View Wiseek Article
INBS
Apr 02, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Intelligent Bio Solutions Completes Key Clinical Study, Advances FDA 510(k) Path for Drug Screening System
Sentiment: Positive
View Wiseek Article
INBS
Mar 23, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Intelligent Bio Solutions Confirms $3.97M ATM Offering, Grants Significant Equity Awards to Executives and Directors Amidst Going Concern Warning
Sentiment: Negative
View Wiseek Article
INBS
Mar 23, 2026, 4:10 PM EDT
Filing Type: 424B5
Importance Score:
9
Intelligent Bio Solutions to Sell Up to $3.97M in Highly Dilutive ATM Offering Amidst Going Concern Warning
Sentiment: Negative
View Wiseek Article
INBS
Feb 25, 2026, 9:15 AM EST
Filing Type: 8-K
Importance Score:
8
Intelligent Bio Solutions Ships First Readers from New Partner, Boosting Margins and Scaling for US Entry
Sentiment: Positive
View Wiseek Article
INBS
Feb 12, 2026, 8:31 AM EST
Filing Type: 10-Q
Importance Score:
9
Intelligent Bio Solutions Discloses Going Concern Doubt, Material Weaknesses, and Details Dilutive Capital Raises
Sentiment: Negative
View Wiseek Article
INBS
Feb 05, 2026, 8:53 AM EST
Filing Type: 8-K
Importance Score:
8
Intelligent Bio Solutions Projects Strong Revenue Growth, Exceeding $2M in H1 Fiscal 2026
Sentiment: Positive
View Wiseek Article
INBS
Jan 28, 2026, 5:15 PM EST
Filing Type: 8-K
Importance Score:
8
Intelligent Bio Solutions Initiates Clinical Study for FDA Submission of Drug Screening System
Sentiment: Positive
View Wiseek Article
INBS
Jan 21, 2026, 5:26 PM EST
Filing Type: 424B3
Importance Score:
9
INTELLIGENT BIO SOLUTIONS REGISTERS 6.9M SHARES FOR RESALE, CREATING SIGNIFICANT OVERHANG AFTER DEEPLY DISCOUNTED PRIVATE PLACEMENT
Sentiment: Negative
View Wiseek Article
INBS
Jan 09, 2026, 5:00 PM EST
Filing Type: S-3
Importance Score:
9
INBS Registers 6.9M Shares for Resale by Institutional Investors, Signaling Massive Potential Dilution
Sentiment: Negative
View Wiseek Article
INBS
Jan 08, 2026, 5:00 PM EST
Filing Type: 8-K
Importance Score:
8
Intelligent Bio Solutions Regains Nasdaq Minimum Bid Price Compliance
Sentiment: Positive
View Wiseek Article
INBS
Jan 02, 2026, 5:11 PM EST
Filing Type: 8-K
Importance Score:
9
Intelligent Bio Solutions Secures $10M in Highly Dilutive Private Placement at Significant Discount
Sentiment: Negative
View Wiseek Article